A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

Clinical trial NCT02453789 · COMPLETED

Trial details

NCT number: NCT02453789
Sponsor: AlgiPharma AS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis Burkholderia Infection

Start date: 2015-02-01
Primary completion: 2017-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.